A REAL-WORLD EFFICACY AND SAFETY ANALYSIS OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE (KRD) COMBINATION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

被引：0
|
作者：
Caratozzolo, I.
Tacchetti, P.
Zambello, R.
Pantani, L.
Antonioli, E.
Mancuso, K.
Buda, G.
Rocchi, S.
Canepa, L.
Rizzello, I.
Gamberi, B.
Barila, G.
Testoni, N.
Marzocchi, G.
Zamagni, E.
Cavo, M.
机构：
[1] Azienda Osped Univ S Orsola Malpighi, Bologna, Italy
[2] Azienda Osped Padova & Veneto, Padua, Italy
[3] Azienda Osped Univ Pisana, Pisa, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P026
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma
    Rocchi, Serena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Rizzello, Ilaria
    di Giovanni Bezzi, Chiara
    Scalese, Marco
    Dozza, Luca
    Marzocchi, Giulia
    Martello, Marina
    Barila, Gregorio
    Antonioli, Elisabetta
    Staderini, Michela
    Buda, Gabriele
    Petrini, Mario
    Cea, Michele
    Quaresima, Micol
    Furlan, Anna
    Bonalumi, Angela
    Cavo, Michele
    Zamagni, Elena
    [J]. HEMATOLOGICAL ONCOLOGY, 2021, 39 (01) : 41 - 50
  • [2] Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
    Onda, Yoshiyuki
    Kanda, Junya
    Kaneko, Hitomi
    Shimura, Yuji
    Fuchida, Shin-ichi
    Nakaya, Aya
    Itou, Tomoki
    Yamamura, Ryosuke
    Tanaka, Hirokazu
    Shibayama, Hirohiko
    Shimazu, Yutaka
    Uchiyama, Hitoji
    Yoshihara, Satoshi
    Adachi, Yoko
    Matsuda, Mitsuhiro
    Hanamoto, Hitoshi
    Uoshima, Nobuhiko
    Kosugi, Satoru
    Ohta, Kensuke
    Yagi, Hideo
    Kanakura, Yuzuru
    Matsumura, Itaru
    Hino, Masayuki
    Nomura, Shosaku
    Shimazaki, Chihiro
    Takaori-Kondo, Akifumi
    Kuroda, Junya
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [3] RAPID AND PERSISTENT EFFICACY OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE (KRD) IN AGGRESSIVE MULTIPLE MYELOMA DISEASE
    Garibaldi, B.
    Condorelli, A.
    Romano, A.
    Del Fabro, V.
    Elia, F.
    Di Raimondo, F.
    Conticello, C.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 168 - 169
  • [4] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Ferrara, K.
    Peluso, I.
    Nappi, D.
    Di Perna, M.
    Zacheo, I.
    Pareto, A. E.
    Pane, F.
    Catalano, L.
    [J]. HAEMATOLOGICA, 2017, 102 : 804 - 804
  • [5] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    [J]. HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [6] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    White, Darrell
    LeBlanc, Richard
    Venner, Chritopher
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Gasparetto, Cristina J.
    Chen, Christine
    Lipe, Brea
    Sutherland, Heather
    Tuchman, Sascha
    Baljevic, Muhamed
    Kotb, Rami
    Sebag, Michael
    Callander, Nancy
    Bensinger, William
    Kai, Kazuharu
    Liu, Jianjun
    Sheehan, Heidi
    Estepan, Daniel Nova
    Shah, Jatin
    Schiller, Gary J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E55 - E55
  • [7] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTRE REAL-LIFE EXPERIENCE
    Guidotti, F.
    Ferla, V
    Gregorini, A., I
    Rossi, F. G.
    Pompa, A.
    [J]. HAEMATOLOGICA, 2018, 103 : 38 - 38
  • [8] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Martinelli, G.
    Nappi, D.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Musuraca, G.
    Lucchesi, A.
    Ferrari, A.
    Simonetti, G.
    Pane, F.
    Catalano, L.
    [J]. HAEMATOLOGICA, 2019, 104 : 71 - 71
  • [9] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S310 - S310
  • [10] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Catalano, Lucio
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S6
12345